Remote Patient Monitoring (RPM) Market

1. Opportunity Analysis and Industry Forecast, 2016-2023 Remote Patient Monitoring Market is Expected to Reach $2,130 million, Globally by 2022 Global Opportunity Analysis and Industry Forecast, 2016-2023

2. REMOTE PATIENT MONITORING MARKET Remote Patient Monitoring (RPM) Market Report, is expected to garner $2,130 million by 2022, registering a CAGR of 17% during the period 2014-2022. Congestive heart failure segment is estimated to lead the market throughout the analysis period, closely followed by diabetes. Three-fourths of the remote patient monitoring market share was captured by North America and Europe in 2015. Remote patient monitoring (RPM) is a technology used to collect medical and health-related data from individuals at one location and electronically transmit it to a healthcare provider at another location. RPM is used to remotely monitor and analyze physiological parameters such as blood oxygen levels, vital signs, blood pressure, heart rate, and blood sugar, which improves the quality of care, quality of life, and allows early prediction of aggravations and exacerbations. This reduces the number of emergency department visits, and duration of hospitalization. This is attributed to the large undiagnosed patient population, improving access to healthcare systems, and a high risk of developing chronic disease due to rapid urbanization. In addition, the increase in incidences of chronic diseases, such as diabetes and COPD, are responsible for the high growth rate.

3. REMOTE PATIENT MONITORING MARKET The congestive heart failure (CHF) is the highest revenue-generating segment in this market owing to the high-risk and life-threatening consequences associated with heart failure, which can be avoided using RPM technologies. In addition, the increase in geriatric population that leads to increase in incidences of age-related heart problems will further drive the market growth. Whereas, diabetes would account for the fastest growing segment owing to the increase in incidence of diabetes, presence of well-established smart glucose monitoring technologies in the market and rise in adoption by end users. The diabetes segment would exhibit significant growth in the Asia-Pacific and LAMEA, supplemented by the increase in awareness and adoption among end users. The devices segment occupied the major market share in 2015, and is expected to grow during the analysis period. This is due to the high one-time capital cost associated with the purchase of RPM devices. Also, improved highly sensitive devices, additional features, and added connectivity will help devices market to grow at a faster pace as compared to software. Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/1727

4. Key Findings of the Remote Patient Monitoring (RPM) Market: • CHF was the leading segment in 2015, and is expected to maintain its lead throughout the analysis period. • Diabetes will be the fastest growing segment throughout the analysis period. • Devices will be both the highest revenue generating and fastest growing segment of the global remote patient monitoring (RPM) market. • Saudi Arabia market for remote patient monitoring is projected to grow at a high CAGR of 21.3%. • U.S. was the largest country market in 2015, and is projected to maintain its lead until 2022. REMOTE PATIENT MONITORING MARKET

5. REMOTE PATIENT MONITORING MARKET According to WHO, the leading causes of deaths in 2012 were: cardiovascular diseases, respiratory diseases, including asthma and chronic obstructive pulmonary disease, and diabetes. These are the major four non-communicable diseases (NCDs) which were responsible for 82% of the deaths worldwide. Remote health monitoring technologies focus on serious, chronic conditions, such as congestive heart failure (CHF), pulmonary fibrosis, and diabetes, as they tend to result in repeated hospitalization. Percentage Of Deaths Caused Due To Non-communicable Diseases (Ncd) In 2012

6. REMOTE PATIENT MONITORING MARKET The report covers the analysis of remote patient monitoring devices market based on conditions, components, and geography. Based on the conditions, the market is categorized into congestive heart failure (CHF), diabetes, chronic obstructive pulmonary disease (COPD), blood pressure, mental health, and others. Based on components, the market is divided into two segments devices and software. Based on geography, the remote patient monitoring industry is studied with respect to four major regions ‐ North America (U.S., Canada, and Mexico); Europe (Germany, France, U.K., Italy, Spain, and Russia); Asia-Pacific (Japan, China, India, Australia, South Korea, and Taiwan); and LAMEA (Brazil, Turkey, Venezuela, Saudi Arabia, and Republic of South Africa). The report includes the revenue generated from the sales of these categories.

7. REMOTE PATIENT MONITORING MARKET Remote Patient Monitoring Market Segmentation

8. REMOTE PATIENT MONITORING MARKET Russia Remote Patient Monitoring Market, 2014-2022 ($Million) The Russian remote patient monitoring industry is projected to grow at a high CAGR of 19.3% during the forecast period. The major factors, such as lack of awareness and issues pertaining to price constraints, restrain the growth of RPM market in this region. However, the presence of untapped market would boost the growth of the market. Also, the increase in focus of the RPM vendors on the emerging markets (such as APAC and LAMEA nations) is primarily set to contribute towards the growth of the market. Check Offers And Discount On This Report : https://www.alliedmarketresearch.com/get-discount/1727

9. REMOTE PATIENT MONITORING MARKET • Contact:Shriram Dighe5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free: +1-800-792-5285UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1⟨855⟩550-5975help@alliedmarketresearch.com • Web: https://www.alliedmarketresearch.com

10. REMOTE PATIENT MONITORING MARKET Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/remote-patient-monitoring-market Follow Us On